CompletedNCT02028533
Intranasal Oxytocin Feasibility Study for People Receiving Methadone and Using Cocaine
About this title
Read the official source — NCT02028533Medication studyAges 18+United StatesAddiction
Understand this study
Who was this study for?
Listed age limits: from 18 years.
- Listed locations
- San FranciscoSee all locations and recruitment
- Study phase
- Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
Study information
Study start dateJuly 2014
- Recruitment status
- Completed
- Enrollment listed in the registry
- 30
- Sponsor
- University of California, San Francisco
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
- Locations
- United States
- Age range
- Over 18 Years
- Official registry ID
- NCT02028533
- Official title
Show the full official title
Chronic Intranasal Oxytocin as an Adjunct to Methadone Maintenance Treatment in Patients With Co-occuring Opioid Use Disorder and Cocaine Use: A 2-week Pilot Study
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
San Francisco
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is University of California, San Francisco, a university.
Did this study involve medication?
Yes. The study involved medication, including Oxytocin and Placebo.
Who was this study for?
Listed age limits: from 18 years.
